Abstract
One of the most popular radioisotopes used in the prostate brachytherapy is Palladium-103 (103 Pd). The radioactive plaque is sewn onto the eye as to cover the intraocular tumor shadow with a 2-3 mm margin. These plaques are temporary and radiation is continuously delivered over 5 to 7 days. At the end of treatment, the plaque is removed from eye. In this study, production cross–section calculations of 103 Pd radionuclide used in brachytherapy produced by 101 Ru(α,2n), 100 Ru(α,n), 102 Ru(3 He,2n) and 101 Ru(3 He,n) reactions have been investigated in the different incident energy range up to 35 MeV. Twocomponent Exciton model and Generalized Superfluid model of the TALYS 1.6 code used to perform calculations and calculation results were compared with experimental results reported in the literature.
Highlights
One of the most popular radioisotopes used in the prostate brachytherapy is Palladium-103 (103Pd)
Radioactive 103Pd is produced in the form of seed. 103Pd seeds are placed into a non-radioactive metallic plaque to apply the uveal melanoma
Production cross–section calculations of 103Pd radionuclide used in brachytherapy produced by 101Ru(α,2n), 100Ru(α,n), 102Ru(3He,2n) and 101Ru(3He,n) reactions have been investigated in the different incident energy range up to 35 MeV
Summary
One of the most popular radioisotopes used in the prostate brachytherapy is Palladium-103 (103Pd). Production cross–section calculations of 103Pd radionuclide used in brachytherapy produced by 101Ru(α,2n), 100Ru(α,n), 102Ru(3He,2n) and 101Ru(3He,n) reactions have been investigated in the different incident energy range up to 35 MeV. Two-component Exciton model and Generalized Superfluid model of the TALYS 1.6 code used to perform calculations and calculation results were compared with experimental results reported in the literature.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
